TABLE 1.
Country breakdown of physician and patient respondents to questionnaires
| Country | Physicians n | Patients | |||
| n |
Female
n (%) |
Use of biologics
n (%) |
Daily OCS
n (%) |
||
| Belgium | 13 | 102 | 57 (56) | 86 (84) | 9 (9) |
| Estonia | 8 | 14 | 13 (93) | 6 (43) | 5 (36) |
| France | 28 | 15 | 10 (67) | 13 (87) | 5 (33) |
| Greece | 18 | 122 | 82 (67) | 74 (60) | 35 (29) |
| Hungary | 40 | 110 | 71 (65) | 71 (65) | 22 (20) |
| Italy | 31 | 52 | 38 (73) | 28 (54) | 13 (25) |
| Latvia | 4 | 54 | 33 (61) | 24 (44) | 19 (35) |
| Lithuania | 15 | 53 | 35 (66) | 41 (77) | 8 (15) |
| The Netherlands | 2 | 114 | 69 (61) | 79 (69) | 27 (24) |
| Romania | 31 | 12 | 5 (42) | 9 (75) | 3 (25) |
| Russian Federation | 13 | 55 | 34 (62) | 11 (20) | 9 (16) |
| Serbia | 15 | 74 | 50 (68) | 45 (60) | 30 (41) |
| Slovenia | 2 | 70 | 51 (73) | 64 (91) | 12 (17) |
| Sweden | 9 | 122 | 60 (49) | 67 (55) | 34 (28) |
| Switzerland | 19 | 57 | 25 (44) | 46 (81) | 19 (33) |
| UK | 20 | 75 | 43 (57) | 45 (60) | 31 (41) |
| Total | 268 | 1101 | 676 (61) | 709 (64) | 281 (26) |
Number of returned physician surveys per country, and number and characteristics of participating patients per country. OCS: oral corticosteroids.